Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 13, 2013 - Issue 2
Submit an article Journal homepage
682
Views
5
CrossRef citations to date
0
Altmetric
Theme: Stroke - Editorial

Stem cell therapy in stroke treatment: is it a viable option?

Osman Mir UT Houston, MSB 7.126, 6431 Fannin Street, Houston, TX 77030, USA
&
Sean I Savitz UT Houston, MSB 7.126, 6431 Fannin Street, Houston, TX 77030, USA. [email protected]
Pages 119-121 | Published online: 09 Jan 2014
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Financial & competing interests disclosure

The authors were funded by the Howard Hughes Medical Institute and the NIH to conduct research in cell therapies in stroke: grant numbers R01NS071127, R21HD060978, R21NS06316 and T31NS007412. SI Savitz served as the senior investigator for the Aldagen clinical trial. SI Savitz undertakes sponsored research with Aldagen, Celgene, Athersys and J&J, and serves as a consulant for Neuralstem and KM Phamaceutical. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Autologous mesenchymal stem cell transplantation in stroke patients.
Source: Wiley
Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease
Source: Ovid Technologies (Wolters Kluwer Health)
Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia.
Source: SAGE Publications
Intravascular cell replacement therapy for stroke
Source: Journal of Neurosurgery Publishing Group (JNSPG)
Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic
Source: Elsevier BV
Intra-Arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients with Moderate to Severe Middle Cerebral Artery Acute Ischemic Stroke:
Source: SAGE Publications
Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats.
Source: Ovid Technologies (Wolters Kluwer Health)
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.
Source: Springer Science and Business Media LLC
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
Source: Massachusetts Medical Society
Blockade of adrenoreceptors inhibits the splenic response to stroke.
Source: Elsevier BV

Linking provided by 
Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.